Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry.
Ontology highlight
ABSTRACT: The development of structure-guided drug discovery is a story of knowledge exchange where new ideas originate from all parts of the research ecosystem. Dorothy Crowfoot Hodgkin obtained insulin from Boots Pure Drug Company in the 1930s and insulin crystallization was optimized in the company Novo in the 1950s, allowing the structure to be determined at Oxford University. The structure of renin was developed in academia, on this occasion in London, in response to a need to develop antihypertensives in pharma. The idea of a dimeric aspartic protease came from an international academic team and was discovered in HIV; it eventually led to new HIV antivirals being developed in industry. Structure-guided fragment-based discovery was developed in large pharma and biotechs, but has been exploited
SUBMITTER: Blundell TL
PROVIDER: S-EPMC5571795 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA